CROI 2023 Program

SCOTT M. HAMMER WORKSHOP FOR NEW INVESTIGATORS AND TRAINEES

Widely considered the most informative and comprehensive session, this workshop highlights key presentations that will take place during CROI. Although the workshop is directed toward new investigators and trainees (eg, undergraduate students, graduate students, postdoctoral fellows, and physician fellows), all CROI attendees are encouraged to attend. Scholarship recipients are required to attend.

Moderators: Nicolas Chomont, Université de Montréal, Montreal, Canada and Serena S. Spudich, Yale University, New Haven, CT, USA

• ADVANCES IN MOLECULAR VIROLOGY OF HIV AND SARS-CoV-2
  Stuart Neil, King’s College London, London, United Kingdom
  
• ADVANCES IN HIV AND SARS-CoV-2 IMMUNOLOGY
  Guido Silvestri, Emory University, Atlanta, GA, USA
  
• ADVANCING RESEARCH: THE POWER OF COMMUNITY ENGAGEMENT
  Dawn Averitt, The Well Project, Women’s Research Initiative on HIV/AIDS, South Strafford, VT, USA
  
• ADVANCES IN HIV TREATMENT STRATEGIES
  Monica Gandhi, University of California San Francisco, San Francisco, CA, USA
  
• ADVANCES IN BIOMEDICAL PREVENTION OF HIV
  Raphael Landovitz, University of California Los Angeles, Los Angeles, CA, USA
• ADVANCES IN HIV CURE
  John Mellors, University of Pittsburgh, Pittsburgh, PA, USA
  
• A CALL TO ACTION FOR NEW INVESTIGATORS: OPPORTUNITIES IN RESEARCH AND PUBLIC HEALTH
  Rochelle Walensky, Centers for Disease Control and Prevention, Atlanta, GA, USA

CONCURRENT TECHNICAL WORKSHOPS

OPENING SESSION

BERNARD FIELDS LECTURE:
MODELING THE DYNAMICS OF HIV INFECTION: ESTABLISHING PARADIGMS FOR TREATMENT AND CURE

Alan S. Perelson, Los Alamos National Laboratory, Los Alamos, NM, USA

The Bernard Fields Lecture recognizes a basic scientist for important and relevant contributions to the fields of virology and viral pathogenesis.

N’GALY-MANN LECTURE:
HIV AND GLOBAL HEALTH IN A PANDEMIC ERA

Kevin M. De Cock, Centers for Disease Control and Prevention (CDC) Mission in Kenya (former), Nairobi, Kenya

The N’Galy-Mann Lecture recognizes an HIV/AIDS researcher for important and relevant work in the fields of epidemiology or clinical research.

MARTIN DELANEY PRESENTATION:
COMMUNITY AND ADVOCATES ARE EQUAL PARTNERS IN RESEARCH AND DEVELOPMENT

Yvette Raphael, Advocacy for Prevention of HIV and AIDS, Midrand, South Africa

The Martin Delaney Presentation recognizes the important contributions of community advocacy and engagement to HIV/AIDS research.

CROI AT 30: PROGRESS IN HIV THROUGH THE LENS OF CROI

Commentaries from HIV research, care, policy, and advocacy leaders look back at past advances through the lens of CROI and forward toward future challenges.

CROI: A 30-YEAR CHRONICLE OF HIV/AIDS RESEARCH PROGRESS

Anthony S. Fauci, National Institute of Allergy and Infectious Diseases, National Institutes of Health (former), Washington, DC

We take the opportunity of the 30th CROI to honor Dr Athony S. Fauci. Dr Fauci will offer personal perspectives from his 40+ years of conducting and overseeing HIV-related science since the start of the AIDS pandemic. The milestones, the lessons learned, the most exciting moments, and how he sees the challenges and opportunities for the next generation of HIV/AIDS scientists.

WELCOME RECEPTION

Immediately Following the Opening Session

MONDAY PLENARY SESSION

20 YEARS OF PEPFAR: LOOKING BACK, STRIDING FORWARD

John Nkengasong, US Department of State, Washington, DC, USA

THE PATH TO HEPATITIS B CURE

Anna Suk-Fong Lok, University of Michigan Medical School, Ann Arbor, MI, USA

CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

• VIROLOGY/PATHOGENESIS
  Moderators: Theodora Hatziioannou, Rockefeller University, New York, NY, USA and Molly Ohainle, University of California Berkeley, Berkeley, CA, USA
  
• TB AND HEPATITIS
  Moderators: Constance A. Benson, University of California San Diego, San Diego, CA, USA and David Wyles, Denver Health Medical Center, Denver, CO, USA
  
• HIV AND STI PREVENTION: NEW TOOLS AND APPROACHES
  Moderators: Adaora Adimora, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and Renee Heffron, University of Alabama at Birmingham, Birmingham, AL, USA
  
• INSIGHTS INTO PREVENTION AND TREATMENT OF HIV IN WOMEN AND CHILDREN
  Moderators: Jennifer Jao, Northwestern University, Chicago, IL, USA and John Kinuthia, Kenyatta National Hospital, Nairobi, Kenya
  

Lunch Break for Attendees

Concurrent Meet the Luminary Sessions for New Investigator Scholarship Recipients

• Meet the Luminary Session With Alan S. Perelson
• Meet the Luminary Session With Anna Suk-Fong Lok
• Meet the Luminary Session With Kevin M. De Cock
• Meet the Luminary Session With Anthony Fauci

CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

• HIV AND THE MICROBIOME: NEW THEMES
  Moderator: Ronald G. Collman, University of Pennsylvania, Philadelphia, PA, USA
  
• STEATOHEPATITIS: SEX DIFFERENCES AND OTHER RISK FACTORS
  Moderator: Susanna Naggie, Duke University, Durham, NC, USA
  
• PREDICTORS OF TB TREATMENT OUTCOMES
  Moderator: Amita Gupta, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
  
• UNDERSTANDING MORTALITY IN PEOPLE WITH HIV
  Moderator: Maureen Syowai, ICAP at Columbia University, Nairobi, Nairobi Area, Kenya
  
• NEW INSIGHTS THROUGH RECENCY TESTING
  Moderator: George W. Rutherford, University of California San Francisco, London, United Kingdom
  

POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

Poster Walks

• Poster Walk With Stuart J.D. Neil
• Poster Walk With John W. Mellors
• Poster Walk With Jürgen K. Rockstroh
• Poster Walk With Annette H. Sohn
• Poster Walk With Jean-Michel Molina
• Poster Walk With Monica Gandhi

CONCURRENT INTERACTIVE SYMPOSIA

VIRAL ORIGINS AND EVOLUTION OF HIV AND SARS-CoV-2

Moderators: Theodora Hatziioannou, The Rockefeller University, New York, NY, USA and Julie Overbaugh, University of Washington, Seattle, WA, USA

• ORIGINS OF HIV-1 AND SARS-CoV-2
  Michael Worobey, University of Arizona, Tucson, AZ, USA
  
• POPULATION-LEVEL EVOLUTION OF HIV-1 AND SARS-CoV-2
  Paul Bieniasz, The Rockefeller University, New York, NY, USA
  
• FROM PROMISE TO REALIZATION: SEQUENCING AND SURVEILLANCE FROM HIV-1 TO SARS-CoV-2
  Emma Hodcroft, University of Bern, Basel, Switzerland
  

FROM ROCKET SCIENCE TO REALITY: MONITORING ANTIRETROVIRALS AND ADHERENCE

Moderators: K. Rivet Amico, University of Michigan, Ann Arbor, MI, USA and Alice Tseng, University Health Network, Toronto, Canada

• THE LANDSCAPE OF ADHERENCE TESTING
  Peter Anderson, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  
• DIGITAL TECHNOLOGIES FOR SUPPORTING ADHERENCE
  Lisa Hightow-Weidman, Florida State University, Pittsboro, NC, USA
  
• MEASURING ADHERENCE WITH LA/ED THERAPIES IN LOW AND MIDDLE INCOME COUNTRIES
  Catherine Orrell, Desmond Tutu Health Foundation, Cape Town, South Africa
  

DELIVERING ON THE SUCCESS OF INJECTABLE PrEP

Moderators: Saiqa Mullick, Wits Reproductive Health and HIV Institute, Johannesburg, South Africa and Christina Psaros, Massachusetts General Hospital, Boston, MA, USA

• FROM EFFICACY TO EFFECTIVENESS: CATALYZING ROLLOUT OF LONG-ACTING PREP
  Nyaradzo Mgodi, University of Zimbabwe, Harare, Zimbabwe
  
• AVOIDING DISPARITIES: NOT MAKING THE SAME MISTAKE AGAIN
  LaRon Nelson, Yale University, New Haven, CT, USA
  
• LA PrEP: WHAT WE KNOW AND WHAT WE STILL NEED TO KNOW
  Sunil Solomon, The Johns Hopkins University School of Medicine, Baltimore, MA, USA
  

TUESDAY PLENARY SESSION

HIV RESERVOIRS: OBSTACLES TO A CURE

Janet Siliciano, Johns Hopkins University School of Medicine, Baltimore, MD, USA

RESTRICTIONS ON REPRODUCTIVE RIGHTS AND THEIR IMPACT ON PEOPLE LIVING WITH HIV

Denise J. Jamieson, Emory University School of Medicine, Decatur, GA, USA

CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

• HIV RESERVIORS AND CURE STRATEGIES
  Moderators: Katharine Bar, University of Pennsylvania, Philadelphia, PA, USA and Linos Vandekerckhove, HIV Cure Research Center, Ghent University, Ghent, Oost-Vlaanderen, Belgium
  
• CONSTERNATION ABOUT COMPLICATIONS
  Moderators: Judith S. Currier, University of California Los Angeles, Los Angeles, CA, USA and Roger Bedimo, University of Texas Southwestern, Dallas, TX, USA
  
• GLOBAL EPIDEMIOLOGY OF HIV
  Moderators: Connie Celum, University of Washington, Seattle, WA, USA and Andrew Mujugira, Makerere University, Auburn, WA, USA
  
• ALL MODES LEAD TO PrEP
  Moderators: Jean-Michel Molina, University of Paris Cité, Hospital Saint Louis/Lariboisière, Paris, Ile-de-France, France and Valdilea Veloso, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil
  
• LATE-BREAKING CLINICAL STUDIES ON COVID-19 AND MPOX
  Moderators: Joseph J. Eron, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and Anne F. Luetkemeyer, University of California San Francisco, San Francisco, CA, USA

Lunch Break for Attendees

Concurrent Meet the Luminary Sessions for New Investigator Scholarship Recipients

• Meet the Luminary Session With Janet Siliciano
• Meet the Luminary Session With Denise J. Jamieson
• Meet the Luminary Session With Paul Lehner
• Meet the Luminary Session With George Kuchel

CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

• DYNAMICS OF PROVIRAL INTEGRATION
  Moderator: Lillian Cohn, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
• A VIRUS ON MY MIND: UNRAVELING LINKS BETWEEN HIV AND MENTAL HEALTH SYMPTOMS
  Moderator: Sean Rourke, University of Toronto, Toronto, ON, Canada
• LAI CAB/RPV: WHERE ARE WE NOW AND WHERE ARE WE GOING?
  Moderator: Babafemi Taiwo, Northwestern University, Chicago, IL, USA
• ADVANCES IN PrEP DELIVERY IN SUB-SAHARAN AFRICA
  Moderator: Andrew Mujugira, Makerere University, Auburn, WA, USA

POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

Poster Walks

• Poster Walk With Katharine J. Bar
• Poster Walk With John M. Coffin
• Poster Walk With Judith S. Currier
• Poster Walk With Peter Reiss
• Poster Walk With Monica Gandhi
• Poster Walk With Raphael J. Landovitz

CONCURRENT INTERACTIVE SYMPOSIA

PEDIATRIC HIV CURE

 Moderator: Deborah Persaud, The Johns Hopkins University, New Haven, CT, USA

• APPROACHES TO PEDIATRIC CURE
  Philip Goulder, University of Oxford, Oxford, United Kingdom
• NONHUMAN PRIMATE STUDIES OF PEDIATRIC CURE INTERVENTIONS
  Ann Chahroudi, Emory Vaccine Center, Atlanta, GA, USA
• PROGRESS IN CLINICAL TRIALS OF PEDIATRIC HIV CURE
  Roger Shapiro, Harvard University, Boston, MA, USA
  

COVID-19: WHERE ARE WE NOW?

Moderators: Carlos del Rio, Emory University, Atlanta, GA, USA, Brenda Crabtree-Ramirez, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico, and Irini Sereti, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA

• FUTURE DIRECTIONS IN OUTPATIENT THERAPY FOR MILD TO MODERATE COVID-19
  Kara Chew, University of California Los Angeles, Los Angeles, CA, USA
  
• VIRAL REBOUND DURING AND AFTER SARS-CoV-2 TREATMENT
  Jonathan Li, Brigham and Women’s Hospital, Cambridge, MA, USA
  
• WHAT WE KNOW NOW ABOUT LONG COVID SYNDROMES
  Michael Peluso, University of California San Francisco, San Francisco, CA, USA
  

GETTING PrEPped (AND PEPped) FOR SEX: FROM HIV TO STIs TO MONKEYPOX

Moderators: Bridget Haire, Kirby Institute, Sydney, Australia and Maryam Shahmanesh, Africa Health Research Institute, Durban, South Africa

• IMPLEMENTING THE PrEP AND PEP TOOLKIT
  Colleen Kelley, Emory University School of Medicine, Atlanta, GA, USA
• PREVENTION OF STIs IN ADULTS AND ADOLESCENTS A SEXUAL REPRODUCTIVE HEALTH PERSPECTIVE
  James Kiarie, World Health Organization, Geneva, Switzerland
• MPOX PREVENTION
  Jade Ghosn, University of Paris Cité Department: Infectious Diseases, Bichat hospital, Paris, France
  

SPECIAL SESSION-1 RESULTS FROM THE MOSAICO HIV VACCINE TRIAL AND FUTURE DIRECTIONS FOR HIV VACCINES

 Moderator: Susan P. Buchbinder, San Francisco Department of Public Health, San Francisco, CA, USA

• OVERVIEW OF THE MOSAICO HIV VACCINE TRIAL
  Susan P. Buchbinder, San Francisco Department of Public Health, San Francisco, CA, USA
• HIV VACCINE DEVELOPMENT POST-MOSAICO
  Lawrence Corey, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  

WEDNESDAY PLENARY SESSION

HOW THE HUSH COMPLEX PROTECTS YOUR GENOME FROM RNA-DERIVED RETROELEMENTS

Paul Lehner, University of Cambridge, Cambridge, United Kingdom

THE SCIENCE OF AGING: LESSONS FOR HIV

George Kuchel, University of Connecticut Health Center, Farmington, CT, USA

CONCURRENT ORAL ABSTRACT SESSIONS

Oral Abstract Sessions include leading-edge research in HIV, hepatitis viruses, SARS-CoV-2, and other viral infections and their related conditions. During these 2-hour sessions, speakers present their peer-reviewed research on a specific topic area and respond to questions from attendees in 1 of 2 question and answer periods moderated by experts in the field.

• IMMUNOPATHOGENESIS AND VACCINES
  Moderators: Richard A. Koup, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA and Cynthia Derdeyn, University of Washington, Seattle, WA, USA
  
• NEUROPATHOGENESIS AND NEUROLOGIC COMPLICATIONS OF HIV AND SARS-COV-2
  Moderators: Serena Spudich, Yale University, New Haven, CT, USA and Michael Corley, Weill Cornell Medicine, New York, NY, USA
  
• ANTIVIRAL STRATEGIES FOR TREATMENT AND PREVENTIONS
  Moderators: Angela D. M. Kashuba, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA and Anton L. Pozniak, Chelsea and Westminster Hospital, London, England, United Kingdom
  
• OPTIMIZING THE HIV TREATMENT CASCADE
  Moderators: Landon Myer, University of Cape Town, Cape Town, Western Cape, South Africa and Euphemia Sibanda, Centre for Sexual Health & HIV/AIDS Research, Harare, Zimbabwe
  
• EPIDEMIOLOGY AND PREVENTION OF MPOX AND SARS-CoV-2
  Moderators: Ruanne Barnabas, Massachusetts General Hospital, Boston, MA, USA and François Dabis, University of Bordeaux, Bordeaux, Aquitaine, France

Lunch Break for Attendees and New Investigator Networking Sessions

Special Session on the MPOX Virus Outbreak

Moderators: Diane V. Havlir, University of California San Francisco, San Francisco, CA, US and Robert Schooley, University of California San Diego, San Diego, CA, US

• STAGE THE SETTING: THE EPIDEMIOLOGY OF THE MPOX VIRUS
  John Brooks, Centers for Disease Control and Prevention, Atlanta, GA, US
• MOLECULAR PATHOGENESIS AND THERAPEUTIC TARGETS FOR MPOX VIRUS
  Stuart N. Isaacs, University of Pennsylvania, Philadelphia, PA, US
• IMMUNOLOGY AND VACCINOLOGY PERSPECTIVES FOR MPOX VIRUS
  Sharon Frey, Saint Louis University, ST LOUIS, MO, US

CONCURRENT THEMED DISCUSSIONS

Themed Discussions include up to 5 select poster abstracts connected by a theme. A discussant provides a 5-minute introduction outlining the state of the topic field, and then each presenter gives a brief overview of their Poster Abstract in 5 minutes using 5 slides (recommended) to summarize the noteworthy results, conclusions, and discussion points. Discussants interact with audience members and presenters to create a discussion that synthesizes the relevant information, covers key points of agreement and controversy, and draws comparisons to related work in the scientific field. At the conclusion of a Themed Discussion, the discussant provides a 5-minute summation highlighting the key information of the Poster Abstracts discussed and posing important questions for future research.

• CELLULAR IMMUNE CONTROL OF HIV
  Moderator: Marcus Altfeld, Leibniz Institute for Virology, Hamburg, Hamburg, Germany
• WEIGHT GAIN: DOES WHAT GOES UP ALWAYS COME DOWN?
  Moderator: Peter W. Hunt, University of California San Francisco, San Francisco, CA, USA
• HIV SERVICES IN TIMES OF CRISIS
  Moderator: Siobhan Crowley, The Global Fund , Geneva, Switzerland
• PRECLINICAL STUDIES OF NEW PREVENTION INTERVENTIONS
  Moderator: Ariane van der Straten, University of California San Francisco, Kensington, CA, USA

POSTER SESSIONS

Poster Abstract Sessions comprise the majority of scientific information presented at CROI. Presenters of Poster Abstracts who attend CROI in-person will be assigned to stand at their respective boards, organized by topic, on one of the three conference days. All posters will be available for viewing throughout the conference in the poster hall and in an electronic format on the CROI website and other electronic means (access is restricted to registered CROI attendees during the conference).

Poster Walks

• Poster Walk With Theodora Hatziioannou 
• Poster Walk With Richard A. Koup
• Poster Walk With Peter W. Hunt
• Poster Walk With Carlos del Rio
• Poster Walk With Ruanne Barnabas
• Poster Walk With Adaora Adimora

CONCURRENT INTERACTIVE SYMPOSIA

THE VIRUSES THEY ARE A CHANGING: HOW THE IMMUNE SYSTEM RESPONDS

Moderators: Shelly Krebs, Henry M Jackson Foundation, Silver Spring, USA and George Lewis, University of Maryland, College Park, MD, USA

• EPITOPE MASKING DURING A RECALL RESPONSE: IMPLICATIONS FOR COVID AND HIV VACCINES
  Facundo Batista, Massachusetts General Hospital, Cambridge, MA, USA
• MEMORY B CELL RESPONSES TO NEW VIRUS VARIANTS: RELEVANCE TO THE CONCEPT OF ORIGINAL ANTIGENIC SIN
  Marion Pepper, University of Washington, Seattle, WA, USA
  
• EFFECT OF NEW VIRAL VARIANTS ON NEUTRALIZING ANTIBODY POTENCY AND BREADTH
  Penny Moore, University of the Witwatersrand, Johannesburg, South Africa
  

CASE-BASED DISCUSSION OF CARDIO-METABOLIC COMPLICATIONS OF HIV AND CONSEQUENCES FOR MANAGEMENT

Moderators: Georg Behrens, Medizinische Hochschule Hannover, Hannover, Germany and Vidya Mave, Center for Infectious Diseases, Pune, India

• CASE 1: CARDIOVASCULAR DISEASE
  Pam Douglas, Duke University School of Medicine, Durham, NC, USA and Ntobeko Ntsui, University of Cape Town, Cape Town, South Africa
  
• CASE 2: WEIGHT GAIN, OBSESITY
  Donal O’Shea, University College Dublin, Dublin, Ireland
  
• CASE 3: NONALCOHOLIC STEATOHEPATITIS/NONALCOHOLIC FATTY LIVER DISEASE
  Giada Sebastiani, McGill University, Montreal, Canada
  

SCIENCE COMMUNICATION IN THE AGE OF MISINFORMATION

Moderators: Jonathan Mermin, Centers for Disease Control and Prevention, Atlanta, GA, USA and Jon Cohen, Science, Cardiff By The Sea, CA, USA

• WHAT CAN I DO? THE CHALLENGE OF HEALTH MISINFORMATION ONLINE
  Emily Vraga, University of Minnesota, Minneapolis, MN, USA
  
• COUNTERING VACCINE AND HEALTH MIS AND DISINFORMATION: AN EVIDENCE-BASED APPROACH
  Scott Ratzan, City University of New York, Princeton, NJ, USA
  
• WHAT’S FUELING THE SPREAD OF MISINFORMATION: LOOKING BEYOND FAKE FACTS
  Heidi Larson, London School of Hygiene & Tropical Medicine, Brussels, Belgium